Evidence map›Paper›PMID 42193695›Full record

ArticleBehavioral sciences (Basel, Switzerland)2026

An AI-Generated Integrated Exercise Addiction Screening Scale (EASS-10): A Methodological Demonstration.

Attila Szabo

Abstract read
In one paragraph

Article in Behavioral sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Attila SzaboDepartment of Psychology and Health Management, Faculty of Health and Sport Sciences, Széchenyi István University, H-9026 Gyor, Hungary.ORCID 0000-0003-2788-4304

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) is increasingly used in scientific research, including psychiatry. Exercise addiction (EA) research relies on self-report instruments, most of which lack a functional impairment criterion and cannot account for obsessive passion, potentially contributing to inflated prevalence estimates and limited clinical specificity. This study examined whether Claude AI (Sonnet 4.6) could assist in synthesizing a brief, theoretically grounded screening tool for EA by integrating validated constructs from the Passion Scale (PS), the Exercise Dependence Scale (EDS), and the Exercise Addiction Inventory (EAI). Using structured prompting and instrument upload, Claude AI created a 10-item scale by systematically mapping source-scale content onto established EA frameworks, including the components model and DSM-5 criteria. The instrument included nine Likert-type items and one binary gate for functional impairment to enhance clinical specificity. Although no empirical validation data were collected, a Monte Carlo simulation (N = 500) was used solely to verify that the prespecified unidimensional simulation model produced internally coherent response patterns. Because the simulated data were generated from and analyzed under the same unidimensional model, these results constitute a computational plausibility check rather than empirical structural validation. AI-assisted theoretical synthesis may offer a novel methodological approach to instrument development, though this remains a working hypothesis requiring empirical corroboration. The proposed Exercise Addiction Screening Scale (EASS-10) is presented as a proof-of-concept tool that now requires empirical validation in clinical and exercise populations.

Indexed as

artificial intelligencehealthphysical activitypsychologyquestionnaire

Identifiers

PMID42193695
PMCPMC13203408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.